ReviewCureus2026
Erbium, Chromium-Doped Yttrium-Scandium-Gallium-Garnet Laser in Endodontics: A Narrative Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erbium, chromium-doped yttrium-scandium-gallium-garnet (Er,Cr:YSGG) laser-assisted endodontics has been investigated as an adjunctive approach to enhance irrigant activation, root canal disinfection, smear layer removal, and cleaning of complex anatomical areas. Owing to its wavelength of approximately 2780 nm, Er,Cr:YSGG laser energy is highly absorbed by water and hydroxyapatite, allowing interaction with both irrigation solutions and dental hard tissues. This interaction may generate photoacoustic streaming, cavitation-like fluid movement, microjet-like hydrodynamic effects, and localized photothermal effects within the root canal system. This narrative review provides a descriptive and critical overview of the mechanisms, clinical applications, current evidence, and limitations of Er,Cr:YSGG laser-assisted endodontics. Available studies have evaluated its use in primary root canal treatment, retreatment procedures, regenerative endodontics, and endodontic microsurgery. Laboratory-based evidence suggests potential benefits in smear layer removal, debris reduction, antimicrobial activity, organic tissue dissolution, irrigant penetration into dentinal tubules, and obturation quality. However, most findings are derived from in vitro or ex vivo studies, and their direct translation to postoperative pain reduction, periapical healing, or long-term clinical success remains uncertain. Current evidence indicates that the efficacy and safety of Er,Cr:YSGG laser-assisted protocols are strongly influenced by laser parameters, tip design, tip position, application time, irrigant type, canal anatomy, and operator experience. Therefore, Er,Cr:YSGG lasers should not be considered a replacement for conventional chemomechanical preparation, but rather as an adjunctive technology that may support standard endodontic protocols when used under appropriate safety-oriented conditions. Further well-designed clinical studies with standardized parameters and long-term outcomes are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.